Table 2. Univariate and Multivariate analysis for positive surgical margins.
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Age | 0.998 | 0.973–1.025 | 0.904 | ||||
| BMI | 1.025 | 0.963–1.091 | 0.441 | ||||
| PSA | 3.432 | 2.317–5.083 | <0.001* | 2.817 | 1.836–4.32 | <0.001* | |
| NLR | 0.952 | 0.841–1.078 | 0.44 | ||||
| PLR | 0.997 | 0.994–1.001 | 0.116 | ||||
| LMR | 1.086 | 0.992–1.189 | 0.074 | 1.124 | 1.018–1.24 | 0.021* | |
| Prognostic nutritional index | 1.013 | 0.979–1.047 | 0.46 | ||||
| Biopsy Gleason sum (≥8 vs. <8) | 1.961 | 1.361–2.826 | <0.001* | 0.902 | 0.566–1.439 | 0.665 | |
| Perineural invasion | 2.985 | 1.907–4.672 | <0.001* | 2.672 | 1.649–4.33 | <0.001* | |
| SVI | 3.501 | 2.026–6.051 | <0.001* | 1.778 | 0.96–3.29 | 0.067 | |
| Pathologic Gleason sum (≥8 vs. <8) | 3.333 | 2.261–4.913 | <0.001* | 2.52 | 1.556–4.082 | <0.001* | |
*, statistically significant. BMI, body mass index; PSA, prostate specific antigen; NLR, neutrophil to lymphocyte ratio; PLR, platelets to lymphocyte ratio; LMR, lymphocyteto monocyte ratio; SVI, seminal vesicle invasion.